SCHEMBL4635178

SCHEMBL4635178

[CH2]CC(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
MAPK1 P28482 2/20 0.44
HIF1A Q16665 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
CHRNA7 P36544 1/20 0.42
LMNA P02545 4/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42
ADRB2 P07550 1/20 0.42
CYP2A6 P11509 1/20 0.42
IDO1 P14902 3/20 0.40
TDO2 P48775 3/20 0.40
GABBR2 O75899 3/20 0.39
GABBR1 Q9UBS5 3/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7429108 0.93 IDO1 (0.50) TSHRTDP1CHRNA7IDO1TDO2
SCHEMBL28759613 0.89 KMT2A (0.46) TSHRMAPK1HIF1ATDP1CHRNA7
SCHEMBL9850891 0.77 TSHR (0.42) TSHRMAPK1HIF1ATDP1LMNA
SCHEMBL7201656 0.76 TSHR (0.46) TSHRMAPK1HIF1ATDP1CHRNA7
SCHEMBL7431436 0.75 SLC6A2 (0.62) TSHRLMNACYP2C9CYP2D6CYP2C19
SCHEMBL5772788 0.75 ADRB2 (0.50) TSHRMAPK1HIF1ATDP1LMNA
SCHEMBL7286544 0.75 AOC3 (0.52) TSHRMAPK1HIF1ATDP1LMNA
SCHEMBL10866105 0.75 ADRB2 (0.50) TSHRMAPK1HIF1ATDP1LMNA
SCHEMBL94275 0.75 HTR2A (0.52) TSHRTDP1LMNA
SCHEMBL1283383 0.74 IDO1 (0.41) TSHRLMNAHPGDIDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP claimed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP claimed
EP-1934182-A1 N-SUBSTITUTED PYRIDINONE OR PYRIMIDINONE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-06-25 EP disclosed
WO-2007044491-A1 N-SUBSTITUTED PYRIDINONE OR PYRIMIDINONE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-19 WO disclosed
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP disclosed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP disclosed